We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NNBR:NASDAQNN, Inc. Analysis

Data as of 2026-04-20 - not real-time

$2.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

NN, Inc. is trading at $2.32, just above its calculated support of $1.32, while the 20‑day SMA ($1.64) sits below the current price, indicating limited short‑term upside. Technicals show a bullish MACD (line above signal) but an RSI of 79.9, flagging an overbought condition that could prompt a pull‑back. The stock’s beta of 2.0 and 30‑day volatility above 116% signal a highly volatile, high‑beta profile. Fundamentally, the company’s forward P/E of 9.94 is far below the industry average of 31.27, and the upside/downside estimate of +137% suggests significant undervaluation despite negative margins and a high debt‑to‑equity ratio. Material news reports an acquisition aimed at expanding in the electric‑grid and data‑center markets, which could improve future growth prospects and mitigate current profitability challenges. Overall, the blend of technical bullishness, strong undervaluation, and strategic acquisition creates a compelling, though risky, investment narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but overbought RSI suggests limited upside
  • Current price near support level
  • High short‑term volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued forward P/E relative to industry
  • Strategic acquisition targeting electric‑grid and data‑center growth
  • Improving upside potential (+137% estimate) despite current earnings weakness

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Fundamental undervaluation and strong upside/downside ratio
  • Diversified global footprint reduces single‑market concentration risk
  • Potential turnaround from acquisition and long‑term industry tailwinds in electrification

Key Metrics & Analysis

Financial Health

Revenue Growth-1.70%
Profit Margin-8.05%
P/E Ratio9.9
ROE-21.15%
ROA-2.52%
Debt/Equity142.53
P/B Ratio3.4
Op. Cash Flow$5.7M
Free Cash Flow$3.3M
Industry P/E31.3

Technical Analysis

TrendNeutral
RSI79.9
Support$1.32
Resistance$2.46
MA 20$1.64
MA 50$1.56
MA 200$1.75
MACDBullish
VolumeIncreasing
Fear & Greed Index87.05

Valuation

Target Price$5.50
Upside/Downside137.07%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.03
Volatility116.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.